| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2023―Oct―05 |
Reply to: Targeted protein S-nitrosylation of ACE2 inhibits SARS-CoV-2 infection |
Chang-ki Oh, Juan Piña-Crespo, Maria Talantova, Lauren N. Carnevale, Charlotte Stoneham, Mary Lewinski, et al. (+2) John Guatelli, Stuart A. Lipton |
| 2 |
[GO] |
2022―Nov―21 |
A potent and broad neutralization of SARS-CoV-2 variants of concern by DARPins |
Vikas Chonira, Young D. Kwon, Jason Gorman, James Brett Case, Zhiqiang Ku, Rudo Simeon, et al. (+15) Ryan G. Casner, Darcy R. Harris, Adam S. Olia, Tyler Stephens, Lawrence Shapiro, Michael F. Bender, Hannah Boyd, I-Ting Teng, Yaroslav Tsybovsky, Florian Krammer, Ningyan Zhang, Michael S. Diamond, Peter D. Kwong, Zhiqiang An, Zhilei Chen |
| 3 |
[GO] |
2022―Sep―29 |
Targeted protein S-nitrosylation of ACE2 inhibits SARS-CoV-2 infection |
Chang-ki Oh, Tomohiro Nakamura, Nathan Beutler, Xu Zhang, Juan Piña-Crespo, Maria Talantova, et al. (+23) Swagata Ghatak, Dorit Trudler, Lauren N. Carnevale, Scott R. McKercher, Malina A. Bakowski, Jolene K. Diedrich, Amanda J. Roberts, Ashley K. Woods, Victor Chi, Anil K. Gupta, Mia A. Rosenfeld, Fiona L. Kearns, Lorenzo Casalino, Namir Shaabani, Hejun Liu, Ian A. Wilson, Rommie E. Amaro, Dennis R. Burton, John R. Yates, Cyrus Becker, Thomas F. Rogers, Arnab K. Chatterjee, Stuart A. Lipton |
| 4 |
[GO] |
2022―Sep―08 |
Converting non-neutralizing SARS-CoV-2 antibodies into broad-spectrum inhibitors |
Payton A.-B. Weidenbacher, Eric Waltari, Izumi de los Rios Kobara, Benjamin N. Bell, Mary Kate Morris, Ya-Chen Cheng, et al. (+3) Carl Hanson, John E. Pak, Peter S. Kim |
| 5 |
[GO] |
2022―Jul―25 |
Cas13d knockdown of lung protease Ctsl prevents and treats SARS-CoV-2 infection |
Zhifen Cui, Cong Zeng, Furong Huang, Fuwen Yuan, Jingyue Yan, Yue Zhao, et al. (+11) Yufan Zhou, William Hankey, Victor X. Jin, Jiaoti Huang, Herman F. Staats, Jeffrey I. Everitt, Gregory D. Sempowski, Hongyan Wang, Yizhou Dong, Shan-Lu Liu, Qianben Wang |
| 6 |
[GO] |
2022―Jun―08 |
Structure and activity of human TMPRSS2 protease implicated in SARS-CoV-2 activation |
Bryan J. Fraser, Serap Beldar, Almagul Seitova, Ashley Hutchinson, Dhiraj Mannar, Yanjun Li, et al. (+8) Daniel Kwon, Ruiyan Tan, Ryan P. Wilson, Karoline Leopold, Sriram Subramaniam, Levon Halabelian, Cheryl H. Arrowsmith, François Bénard |
| 7 |
[GO] |
2022―Jun―02 |
A dimeric proteomimetic prevents SARS-CoV-2 infection by dimerizing the spike protein |
Bhavesh Khatri, Ishika Pramanick, Sameer Kumar Malladi, Raju S. Rajmani, Sahil Kumar, Pritha Ghosh, et al. (+8) Nayanika Sengupta, R. Rahisuddin, Narender Kumar, S. Kumaran, Rajesh P. Ringe, Raghavan Varadarajan, Somnath Dutta, Jayanta Chatterjee |
| 8 |
[GO] |
2022―Jan―19 |
Engineered ACE2 decoy mitigates lung injury and death induced by SARS-CoV-2 variants |
Lianghui Zhang, Soumajit Dutta, Shiqin Xiong, Matthew Chan, Kui K. Chan, Timothy M. Fan, et al. (+9) Keith L. Bailey, Matthew Lindeblad, Laura M. Cooper, Lijun Rong, Anthony F. Gugliuzza, Diwakar Shukla, Erik Procko, Jalees Rehman, Asrar B. Malik |
| 9 |
[GO] |
2021―Nov―09 |
Sialic acid-containing glycolipids mediate binding and viral entry of SARS-CoV-2 |
Linh Nguyen, Kelli A. McCord, Duong T. Bui, Kim M. Bouwman, Elena N. Kitova, Mohamed Elaish, et al. (+18) Dhanraj Kumawat, Gour C. Daskhan, Ilhan Tomris, Ling Han, Pradeep Chopra, Tzu-Jing Yang, Steven D. Willows, Andrew L. Mason, Lara K. Mahal, Todd L. Lowary, Lori J. West, Shang-Te Danny Hsu, Tom Hobman, Stephen M. Tompkins, Geert-Jan Boons, Robert P. de Vries, Matthew S. Macauley, John S. Klassen |
| 10 |
[GO] |
2021―Nov―09 |
Host glycolipids in SARS-CoV-2 entry |
Ryuta Uraki, Yoshihiro Kawaoka |
| 11 |
[GO] |
2020―Oct―22 |
SARS-CoV-2 Mpro inhibitors and activity-based probes for patient-sample imaging |
Wioletta Rut, Katarzyna Groborz, Linlin Zhang, Xinyuanyuan Sun, Mikolaj Zmudzinski, Bartlomiej Pawlik, et al. (+6) Xinyu Wang, Dirk Jochmans, Johan Neyts, Wojciech Młynarski, Rolf Hilgenfeld, Marcin Drag |
| 12 |
[GO] |
2020―Oct―20 |
Bi-paratopic and multivalent VH domains block ACE2 binding and neutralize SARS-CoV-2 |
Colton J. Bracken, Shion A. Lim, Paige Solomon, Nicholas J. Rettko, Duy P. Nguyen, Beth Shoshana Zha, et al. (+9) Kaitlin Schaefer, James R. Byrnes, Jie Zhou, Irene Lui, Jia Liu, Katarina Pance, Xin X. Zhou, Kevin K. Leung, James A. Wells |
|
